Concepedia

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

Ghaith Abu‐Zeinah, Spencer Krichevsky, Tatiana Cruz, Gabriela Hoberman, Diana Jaber, Niamh Savage, Claudia Sosner, Ellen K. Ritchie, Joseph M. Scandura, Richard T. Silver

Leukemia · 2021 · 109 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

Tiziano Barbui, Giovanni Barosi, Gunnar Birgegård et al. · Journal of Clinical Oncology · 2011 · 834 citations · Full text

, , +17

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

Roberto Marchioli, Guido Finazzi, Giorgina Specchia et al. · New England Journal of Medicine · 2012 · 820 citations · Full text

, , +10

Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

Roberto Marchioli, Guido Finazzi, Raffaele Landolfi et al. · Journal of Clinical Oncology · 2005 · 719 citations

, , +12

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

Jean‐Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret et al. · Blood · 2008 · 570 citations · Full text

, , +7

Diagnosis and classification of the polycythemias.

Nathaniel I. Berlin · PubMed · 1975 · 559 citations

, , +5